Financial Performance - Total revenue for the year ended December 31, 2024, was HKD 775,302,000, representing an increase of 4.83% compared to HKD 739,438,000 in 2023[4] - The total profit for the year was HKD 474,594,000, up from HKD 430,120,000 in the previous year, marking an increase of 10.31%[4] - The net loss for the year was HKD 708,763,000, compared to a loss of HKD 184,764,000 in 2023, indicating a significant increase in losses[4] - The basic and diluted loss per share for the year was HKD 0.74, compared to HKD 0.16 in 2023[4] - The company reported a total loss before tax of HKD 185,960,000 for the period[17] - The company reported a net loss of HKD 8,735,000 for 2024, compared to a net loss of HKD 9,771,000 in 2023, indicating an improvement in financial performance[24] - The company recorded a consolidated loss attributable to shareholders of HKD 684 million for the year ended December 31, 2024, compared to a loss of HKD 146 million for the year ended December 31, 2023[35] Assets and Liabilities - Non-current assets decreased to HKD 2,945,425,000 from HKD 3,185,187,000, a decline of 7.53%[6] - Current assets also decreased to HKD 558,582,000 from HKD 791,143,000, representing a decrease of 29.29%[6] - Total liabilities increased to HKD 1,431,079,000 from HKD 1,148,807,000, reflecting a rise of 24.61%[7] - The company's equity attributable to shareholders decreased to HKD 1,776,800,000 from HKD 2,495,761,000, a decline of 28.87%[7] - The total assets of the group amounted to 3,504,007 thousand HKD, with total liabilities of 1,431,079 thousand HKD[16] - Total assets were valued at HKD 3,976,330,000, while total liabilities amounted to HKD 1,151,807,000[17] - As of December 31, 2024, the group's total assets amounted to HKD 3,500,000,000, down from HKD 4,000,000,000 in 2023[56] - The group's total liabilities increased to HKD 1,400,000,000 as of December 31, 2024, compared to HKD 1,200,000,000 in 2023[56] Revenue Segments - The total revenue for the healthcare services segment was 727,796 thousand HKD, with a segment loss of 34,755 thousand HKD[16] - Revenue from the food manufacturing segment was HKD 348,155,000, up from HKD 324,523,000, reflecting a growth of 7.31%[21] - The restaurant operations segment generated revenue of HKD 376,103,000, compared to HKD 359,901,000, marking a 4.45% increase[21] - Total revenue from customer contracts for the year ending December 31, 2024, is HKD 737,124,000, an increase from HKD 697,279,000 in 2023, representing a growth of approximately 5.7%[22] - Revenue from food manufacturing business for 2024 is HKD 348,155,000, up from HKD 324,523,000 in 2023, indicating a growth of about 7.3%[22] - Restaurant operations revenue for 2024 is HKD 376,103,000, compared to HKD 359,901,000 in 2023, reflecting an increase of approximately 4.5%[22] - Revenue from a major customer in the food business amounted to HKD 119,811,000, an increase from HKD 114,667,000 in 2023[20] Expenses - The company reported a significant increase in administrative expenses to HKD 409,194,000 from HKD 399,602,000, an increase of 2.96%[4] - Other operating expenses rose to HKD 181 million, up from HKD 145 million in 2023, mainly due to increased legal and professional fees[36] - Total employee costs for 2024 amount to HKD 297,412,000, slightly up from HKD 289,919,000 in 2023, reflecting an increase in operational expenses[25] Fair Value and Investments - The fair value loss on investment properties was HKD 37,162,000, compared to a loss of HKD 25,684,000 in 2023[4] - The group reported a fair value loss of 37,162 thousand HKD on investment properties during the reporting period[16] - The fair value loss on financial instruments for 2024 is HKD 63,299,000, compared to a gain of HKD 19,912,000 in 2023, highlighting a significant negative shift[25] - The net fair value loss from securities investments was HKD 66,000,000, compared to a gain of HKD 20,000,000 in 2023, resulting in a loss of HKD 55,000,000 for the year[39] - As of December 31, 2024, the financial and securities investment portfolio decreased to HKD 792,000,000 from HKD 1,057,000,000 in 2023[40] Corporate Governance - The company is committed to high-quality corporate governance practices, ensuring compliance with legal and professional standards[64] - An audit committee has been established, consisting of two independent non-executive directors and one non-executive director, to review accounting principles and financial reporting matters[65] - The independent auditor, Ernst & Young, confirmed that the financial figures in the preliminary announcement are consistent with the group's financial report for the year ending December 31, 2024[66] Dividends - The company did not recommend any final dividend for the year ended December 31, 2024, consistent with 2023[31] - The company has decided not to recommend any final dividend for the year ending December 31, 2024, consistent with the previous year[62]
力宝华润(00156) - 2024 - 年度业绩